Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjuvant bisphosphonate therapy: the future.

A H Paterson1

  • 1Department of Medicine, Tom Baker Cancer Centre, 1331-29 S NW, Calgary, Canada.

Seminars in Oncology
|September 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in Canada.

Journal of medical economics·2014
Same author

A detailed RFLP map of Sorghum bicolor x S. propinquum, suitable for high-density mapping, suggests ancestral duplication of Sorghum chromosomes or chromosomal segments.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Assessment of DNA pooling strategies for mapping of QTLs.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

The distribution of Gossypium hirsutum chromatin in G. barbadense germ plasm: molecular analysis of introgressive plant breeding.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Three genetic systems controlling growth, development and productivity of rice (Oryza sativa L.): a reevaluation of the 'Green Revolution'.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

Types, levels and patterns of low-copy DNA sequence divergence, and phylogenetic implications, for Gossypium genome types.

Heredity·2012
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Bisphosphonates show potential in preventing cancer spread to bone, but adjuvant therapy results are conflicting. Further trials are needed to confirm benefits and assess newer, potent bisphosphonates for breast cancer patients.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Bisphosphonates are used for skeletal metastases in breast cancer and multiple myeloma.
  • Emerging research explores their preventive role in adjuvant therapy for operable breast cancer.

Purpose of the Study:

  • To evaluate the efficacy of bisphosphonates as adjuvant therapy in breast cancer.
  • To assess their impact on preventing bone and visceral metastases and improving survival.

Main Methods:

  • Review of three completed adjuvant trials of oral clodronate in breast cancer patients.
  • Analysis of conflicting results regarding metastases and survival outcomes.

Main Results:

  • One study showed reduced bone/visceral metastases and increased survival with adjuvant clodronate.

Related Experiment Videos

  • Another study indicated increased visceral metastases and decreased survival.
  • An interim analysis of a larger trial suggested a benefit for bone metastases only.

    • Conclusions:

    • Conflicting results necessitate further investigation into bisphosphonates for adjuvant breast cancer therapy.
    • Ongoing and planned trials with various bisphosphonates (clodronate, pamidronate, zoledronate, ibandronate) are crucial.
    • Patient selection, trial design, and formulation (oral vs. IV, potency) are key for future studies.